Albumin Dosing for Spontaneous Bacterial Peritonitis
For cirrhotic patients with spontaneous bacterial peritonitis (SBP), administer IV albumin at 1.5 g/kg on day 1 and 1.0 g/kg on day 3, in addition to antibiotics—this regimen reduces both acute kidney injury (10% vs 33%) and mortality (10% vs 29%) compared to antibiotics alone. 1
Standard Dosing Regimen
The evidence-based albumin protocol for SBP is:
- Day 1: 1.5 g/kg body weight IV
- Day 3: 1.0 g/kg body weight IV
This dosing was established in the landmark multi-center RCT and has been consistently validated across multiple meta-analyses 1, 2. The mechanism works by counteracting systemic inflammation-induced vasodilation and restoring effective arterial blood volume, thereby preventing progression to hepatorenal syndrome 1.
Who Benefits Most
Prioritize albumin administration in patients with:
- Serum bilirubin >4 mg/dL
- Baseline creatinine >1.0 mg/dL
- Blood urea nitrogen >30 mg/dL
These high-risk patients derive the greatest mortality benefit from albumin therapy 1. However, current guidelines recommend albumin for all SBP patients, as the intervention significantly reduces both renal dysfunction and death across the board 1, 2.
Critical Contraindications: Heart Failure and Pulmonary Edema
If the patient has overt heart failure or severe pulmonary edema, DO NOT administer the standard albumin dose. This is a critical clinical decision point that requires immediate recognition.
Management Algorithm for Volume Overload:
- Assess volume status before each infusion: Look for jugular venous distension, pulmonary rales, peripheral edema, and oxygen saturation
- Consider dose reduction: Studies show that even lower doses (10 g/day on days 1-3 or 0.75 g/kg + 0.5 g/kg) still reduce renal dysfunction (7% vs 20%) and mortality (27% vs 40%) 1, 3
- Extend infusion time: Standard 6-hour infusions cause symptomatic circulatory overload in the majority of patients; consider infusing over 12-24 hours to reduce acute volume expansion 4
- Monitor closely: Stop infusion immediately if respiratory distress develops
- Use diuretics strategically: In patients with fluid overload and hypoproteinemia, albumin combined with loop diuretics may be appropriate 5
Practical Considerations:
The FDA labeling specifically notes that albumin is hyperoncotic and expands plasma volume by 3-4 times the administered volume by drawing fluid from interstitial spaces 5. In patients with pre-existing heart failure or pulmonary edema, this volume expansion can be catastrophic.
A reduced-dose regimen (0.75 g/kg day 1,0.5 g/kg day 3) may be safer in volume-overloaded patients, though this requires careful clinical judgment as it deviates from guideline recommendations 4, 3. One study found that standard doses infused over 6 hours caused symptomatic circulatory overload in 100% of patients, necessitating premature discontinuation 4.
Important Caveats
- SBP-specific indication: Do NOT use albumin for other infections in cirrhosis (pneumonia, UTI, etc.) unless acute kidney injury develops—these patients show no mortality benefit and increased pulmonary edema risk 1
- Timing matters: Administer albumin as soon as SBP is diagnosed, concurrent with antibiotic initiation 1, 2
- Not a substitute for antibiotics: Albumin is adjunctive therapy; third-generation cephalosporins remain first-line for community-acquired SBP 2
- Cap the dose: Consider a maximum of 100 g per day to avoid volume overload complications 1
Monitoring Requirements
Repeat diagnostic paracentesis at 48 hours to assess treatment response (PMN count should decrease >25% from baseline). If inadequate response occurs, broaden antibiotic coverage but continue albumin as planned 2.
The evidence consistently demonstrates that albumin administration in SBP prevents the progression from infection to acute kidney injury to hepatorenal syndrome—the cascade that drives mortality in these patients 1, 6. However, clinical judgment must prevail when volume overload is present or develops during treatment.